Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
SK Group
Manufacturing
SK Bioscience ponies up $244M for 60% stake in IDT Biologika
SK Bioscience has acquired a 60% stake in IDT Biologika, a German CDMO that specializes in vaccine production, for 339 billion won ($244 million).
Kevin Dunleavy
Jun 27, 2024 11:50am
Takeda-Denali, Daiichi Sankyo, J&J-Legend—Fierce Pharma Asia
Jan 14, 2022 9:15am
South Korea's SK commits $350M as part of CDMO plans
Jan 11, 2022 9:20am
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
Nov 19, 2021 8:20am
SK Life’s dual TV ads for Xcopri target both docs and patients
May 11, 2021 10:25am
SK Life Science debuts Xcopri virtual experience for HCPs
Dec 15, 2020 9:52am
